Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | AMBR Amber International Holding Ltd | 13G/A | 5.33% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | HPLT Home Plate Acquisition Corporation Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Michael J. Saylor | MSTR Strategy Inc | 13G/A | 13.9% | Dec 31, 2023 | 2y |
| CI INVESTMENTS INC. | HESM Hess Midstream LP | 13G/A | 2.87% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | SPR Spirit Aerosystems Holdings, Inc. | 13G/A | 8.6% | Dec 31, 2023 | 2y |
| Black Horse Capital LP | BXRX Baudax Bio, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | PTCT Ptc Therapeutics, Inc. | 13G | 9.1% | Dec 31, 2023 | 2y |
| NOMURA HOLDINGS INC | TRLV Trulieve Cannabis Corp. | 13G | 7.3% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | CEG Constellation Energy Corp | 13G | 6.1% | Dec 31, 2023 | 2y |
| Jin Qiong | GDHG Golden Heaven Group Holdings Ltd. | 13G | 29% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | CNM Core & Main, Inc. | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Riel B.V. | TIXT TELUS International (Cda) Inc. Subordinate Voting Shares | 13G/A | 39.2% | Dec 31, 2023 | 2y |
| Berkshire Hathaway Inc | GL Globe Life Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| SVB FINANCIAL GROUP | ROOT Root, Inc. | 13G/A | 8.2% | Dec 31, 2023 | 2y |
| HG Vora Capital Management, LLC | BALY Bally's Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | RRGB Red Robin Gourmet Burgers Inc | 13G/A | 0% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | ALBO Albireo Pharma, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Atlas Merchant Capital LLC | LOCC Live Oak Crestview Climate Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | DAVA Endava plc | 13G/A | 17.8% | Dec 31, 2023 | 2y |
| Blue Owl Capital Holdings LP | ENGN enGene Therapeutics Inc. | 13G | 5.32% | Dec 31, 2023 | 2y |
| Harvey Partners, LLC | THR Thermon Group Holdings, Inc. | 13G/A | 4.4% | Dec 31, 2023 | 2y |
| MACKENZIE FINANCIAL CORP | CRI Carters Inc | 13G/A | 0% | Dec 31, 2023 | 2y |
| Randall J. Levitt | CBNK Capital Bancorp Inc | 13G/A | 7.32% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | COR Cencora, Inc. | 13G | 5.4% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | MBAC M3-Brigade Acquisition II Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | XPRO Expro Ltd | 13G | 6.7% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | ROSE Rose Hill Acquisition Corporation Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | IPCI Intellipharmaceuticals International Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| CVC Credit Partners, LLC | VNTR Venator Materials PLC | 13G | 6.6% | Dec 31, 2023 | 2y |
| Calamos Market Neutral Income Fund, a series of Calamos Investment Trust | AEAE AltEnergy Acquisition Corp | 13G | 0% | Dec 31, 2023 | 2y |
| GCM Investments GP, LLC | CART Maplebear Inc. | 13G | 3.2% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | AXAC AXIOS Sustainable Growth Acquisition Corporation | 13G/A | 0% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | CNGL Canna-Global Acquisition Corp. Class A Common Stock | 13G | 9.27% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | ESPR Esperion Therapeutics, Inc. | 13G/A | 0.2% | Dec 31, 2023 | 2y |
| Point72 Asset Management, L.P. | ANAB Anaptysbio, Inc | 13G/A | 3% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | CBAY Cymabay Therapeutics | 13G/A | 3.5% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | PMT PennyMac Mortgage Investment Trust | 13G | 7% | Dec 31, 2023 | 2y |
| TURTLE CREEK ASSET MANAGEMENT INC. | ECPG Encore Capital Group Inc | 13G/A | 8.6% | Dec 31, 2023 | 2y |
| EMINENCE CAPITAL, LP | ETWO E2open Parent Holdings, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | MPWR Monolithic Power Systems, Inc. | 13G | 4.6% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | TDY Teledyne Technologies Inc | 13G/A | 10.4% | Dec 31, 2023 | 2y |
| Solel Partners LP | LAW CS Disco, Inc. | 13G | 5.5% | Dec 31, 2023 | 2y |
| Commodore Capital LP | VRDN Viridian Therapeutics, Inc.DE | 13G/A | 3.7% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | NNAG 99 Acquisition Group Inc. Class A Common Stock | 13G | 5.28% | Dec 31, 2023 | 2y |
| Eric Remer | EVCM EverCommerce Inc. | 13G/A | 8.1% | Dec 31, 2023 | 2y |
| Mudrick Capital Management, L.P. | EVTL Vertical Aerospace Ltd. | 13G/A | 10.4% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | NCAC Newcourt Acquisition Corp Class A Ordinary Share | 13G/A | 0.21% | Dec 31, 2023 | 2y |
| M3 Funds, LLC | PROV Provident Financial Holdings Inc | 13G/A | 9.3% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | OPA Magnum Opus Acquisition Limited | 13G | 9.15% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | TRDA Entrada Therapeutics, Inc. | 13G/A | 9% | Dec 31, 2023 | 2y |